Wednesday, 31 July 2013

New Diabetes Update: National Diabetes Inpatient Audit England & Wales 2012

In hospitals around the UK, diabetes teams complain that their attempts to up-skill healthcare professionals are thwarted by last minute withdrawals due to staff shortages on the wards. Until this is met head-on, we will continue to see high-profile disasters on programmes such as ‘Week in, week out’ (‘Wales's Diabetes Disgrace’ 2012) and massive pay-outs will stretch already limited NHS funds (Glycosmedia)


Novel Role of Parathyroid Hormone-Related Protein in the Pathophysiology of the Diabetic Kidney: Evidence from Experimental and Human Diabetic Nephropathy

Collectively, these results indicate that the renal PTHrP/PTH1R system is upregulated in experimental as well human diabetes, appears to be involved with renal hypertrophy, and adversely affects the outcome of DN (Journal of Diabetes Research)


First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes

Boehringer Ingelheim and Lilly initiate post-marketing trial with a planned enrollment of more than 8,000 adults with type 2 diabetes in 24 countries (Lilly)


Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia

This first 10-year nationwide population-based prospective matched control cohort study showed increased risks of initiation of anti-diabetic and anti-hyperlipidemia medications among patients with BD and schizophrenia. No significant increased risk was noted among the patients with MDD (Journal of Affective Disorders)


No comments:

Post a Comment